Research progress on the effects of bezafibrate on glucose and lipid metabolism_Kain Industrial Additives

Fibates have withstood a large number of clinical applications around the world and have been proven to reduce triglycerides and increase high-density lipoprotein levels by activating peroxidase proliferator-activated receptors (PPAR). Fibrates, lipid-lowering drugs, not only regulate lipids but also have certain hypoglycemic effects. Fibates have withstood a large number of clinical applications around the world…